{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:33:04Z","timestamp":1791318784081,"version":"4.3.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T00:00:00Z","timestamp":1452556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001412","name":"CSIR","doi-asserted-by":"publisher","award":["BSC 0112"],"award-info":[{"award-number":["BSC 0112"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"CSIR","doi-asserted-by":"publisher","award":["ESC 0103"],"award-info":[{"award-number":["ESC 0103"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ijpddr.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T18:10:00Z","timestamp":1452795000000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B"],"prefix":"10.1016","volume":"6","author":[{"given":"Sanketkumar","family":"Pandya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Khare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brajendra","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dadi A.","family":"Srinivasarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5503-0694","authenticated-orcid":false,"given":"Amit","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2016.01.001_bib1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/15216540310001639265","article-title":"The anti-parasitic effects of nitric oxide","volume":"55","author":"Ascenzi","year":"2003","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2217\/nnm.14.182","article-title":"Targeted chemotherapy of visceral leishmaniasis by lactoferrin-appended amphotericin B-loaded nanoreservoir: in\u00a0vitro and in\u00a0vivo studies","volume":"10","author":"Asthana","year":"2015","journal-title":"Nanomedicine Lond."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1128\/AAC.01984-12","article-title":"Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules","volume":"57","author":"Asthana","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.it.2015.01.003","article-title":"Nitric oxide synthase in innate and adaptive immunity: an update","volume":"36","author":"Bogdan","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.27.2.172","article-title":"Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.","volume":"27","author":"Brajtburg","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.phrs.2009.11.002","article-title":"Nitric oxide: a short lived molecule stays alive","volume":"61","author":"Brune","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib8","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.2217\/nnm.12.74","article-title":"Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in\u00a0vitro and in\u00a0vivo studies","volume":"7","author":"Costa Lima","year":"2012","journal-title":"Nanomedicine Lond."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.nano.2013.12.013","article-title":"Crucial CD8(+) T-lymphocyte cytotoxic role in amphotericin B nanospheres efficacy against experimental visceral leishmaniasis","volume":"10","author":"Costa Lima","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0140-6736(91)91708-3","article-title":"Liposomal amphotericin B in drug-resistant visceral leishmaniasis","volume":"337","author":"Davidson","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/49.suppl_1.37","article-title":"Amphotericin B nephrotoxicity","volume":"49","author":"Deray","year":"2002","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fimmu.2014.00544","article-title":"Evolutionary roots of arginase expression and regulation","volume":"5","author":"Dzik","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib14","series-title":"Intravenous Medications: a Handbook for Nurses and Health Professionals","first-page":"2016","author":"Gahart","year":"2016"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib15","doi-asserted-by":"crossref","first-page":"e0117977","DOI":"10.1371\/journal.pone.0117977","article-title":"The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs","volume":"10","author":"Gatto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4049\/jimmunol.144.1.278","article-title":"Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism","volume":"144","author":"Green","year":"1990","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib17","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11095-014-1571-4","article-title":"Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis","volume":"32","author":"Gupta","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/10611860701453836","article-title":"Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis","volume":"15","author":"Gupta","year":"2007","journal-title":"J.\u00a0Drug Target"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib19","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s12010-014-1084-y","article-title":"Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles","volume":"174","author":"Jain","year":"2014","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib20","first-page":"389","article-title":"Drug unresponsiveness & combination therapy for kala-azar","volume":"123","author":"Jha","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib21","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dks286","article-title":"Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis","volume":"67","author":"Kansal","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/ed079p1427","article-title":"Nitrogen-based diazeniumdiolates: versatile nitric oxide-releasing compounds for biomedical research and potential clinical applications","volume":"79","author":"Keefer","year":"2002","journal-title":"J.\u00a0Chem. Educ."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib23","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2008.08.065","article-title":"Cysteine proteinase type III is protective against Leishmania infantum infection in BALB\/c mice and highly antigenic in visceral leishmaniasis individuals","volume":"26","author":"Khoshgoo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157018007778992928","article-title":"Effects of nitric oxide donors on the biological activity of human neutrophils in\u00a0vitro. Review own studies","volume":"4","author":"Klink","year":"2007","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.45.2.553-562.2001","article-title":"Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers","volume":"45","author":"Larabi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib26","doi-asserted-by":"crossref","first-page":"18709","DOI":"10.1074\/jbc.273.30.18709","article-title":"Diffusion-limited reaction of free nitric oxide with erythrocytes","volume":"273","author":"Liu","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib27","doi-asserted-by":"crossref","first-page":"754965","DOI":"10.1155\/2014\/754965","article-title":"Innate immunity to leishmania infection: within phagocytes","volume":"2014","author":"Lopes","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejps.2011.09.017","article-title":"Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis","volume":"45","author":"Lopes","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib29","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(05)79119-4","article-title":"Treatment of cutaneous leishmaniasis with nitric-oxide donor","volume":"351","author":"Lopez-Jaramillo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(10)70320-0","article-title":"Visceral leishmaniasis: elimination with existing interventions","volume":"11","author":"Matlashewski","year":"2011","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jconrel.2013.01.035","article-title":"Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer","volume":"169","author":"Mi","year":"2013","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17425247.2014.885500","article-title":"Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis","volume":"11","author":"Moreno","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1166\/jbn.2011.1274","article-title":"Nanoparticles containing nitric oxide donor with antileishmanial agent for synergistic effect against visceral leishmaniasis","volume":"7","author":"Pandya","year":"2011","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib35","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.93.20.10984","article-title":"Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages","volume":"93","author":"Proudfoot","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib36","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/ni1102-1041","article-title":"Evasion of innate immunity by parasitic protozoa","volume":"3","author":"Sacks","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jac\/dkl533","article-title":"Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra","volume":"59","author":"Sharma","year":"2007","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1550-7408.1958.tb02565.x","article-title":"An eight-day method for screening compounds against leishmania donovani in the Golden hamster*","volume":"5","author":"Stauber","year":"1958","journal-title":"J.\u00a0Protozool."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jconrel.2012.05.037","article-title":"PLGA nanoparticles and nanosuspensions with amphotericin B: potent in\u00a0vitro and in\u00a0vivo alternatives to Fungizone and AmBisome","volume":"161","author":"Van de Ven","year":"2012","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib42","first-page":"7","article-title":"Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis","author":"Verma","year":"2013","journal-title":"Tuberc. Edinb."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1166\/jbn.2011.1230","article-title":"Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles","volume":"7","author":"Verma","year":"2011","journal-title":"J.\u00a0Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib44","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1021\/mp300269g","article-title":"Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis","volume":"9","author":"Verma","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpddr.2016.01.001_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2006.07.023","article-title":"Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs","volume":"115","author":"Wang","year":"2006","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10048-010-0268-z","article-title":"Hydroxyurea enhances SMN2 gene expression through nitric oxide release","volume":"12","author":"Xu","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ijpddr.2016.01.001_bib47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1525-1373.2000.22525.x","article-title":"Nitric oxide donors","volume":"225","author":"Yamamoto","year":"2000","journal-title":"Proc. Soc. Exp. Biol. Med."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:43:56Z","timestamp":1761921836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320716300021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S2211320716300021"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.01.001","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}